bluebird bio Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	24,829	20,302	13,576	10,351
Revenue Growth (YoY)	22.30%	49.55%	31.15%	-
Cost of Revenue	16,769	14,303	9,729	7,107
Gross Profit	8,060	5,999	3,847	3,244
Selling, General & Admin	2,355	1,929	1,271	780.43
Research & Development	104.87	85	32.3	17.15
Operating Expenses	2,460	2,018	1,307	799.37
Operating Income	5,601	3,981	2,539	2,444
Interest Expense	-6.37	-14.7	-9.19	-5.97
Interest & Investment Income	107.02	53.8	44.32	38.22
Earnings From Equity Investments	-3.02	0.2	-0.18	-
Currency Exchange Gain (Loss)	5.62	31.96	-0.16	-0.99
Other Non Operating Income (Expenses)	67.42	113.32	58.42	73.11
EBT Excluding Unusual Items	5,771	4,166	2,633	2,549
Gain (Loss) on Sale of Investments	45.17	53.33	25.64	26
Gain (Loss) on Sale of Assets	-5.84	0.2	-0.3	-1.16
Asset Writedown	-	-65.52	-	-14.83
Pretax Income	5,811	4,154	2,658	2,559
Income Tax Expense	1,356	967.4	644.95	646.93
Earnings From Continuing Operations	4,454	3,187	2,013	1,912
Minority Interest in Earnings	-17.7	-49.26	-16.38	-1.58
Net Income	4,437	3,137	1,997	1,910
Net Income to Common	4,437	3,137	1,997	1,910
Net Income Growth	41.41%	57.13%	4.52%	-
Shares Outstanding (Basic)	360	360	360	359
Shares Outstanding (Diluted)	360	360	360	359
Shares Change (YoY)	-	-	0.25%	-
EPS (Basic)	12.32	8.71	5.55	5.32
EPS (Diluted)	12.32	8.71	5.55	5.32
EPS Growth	41.45%	57.04%	4.26%	-
Free Cash Flow	4,570	2,109	1,433	747.87
Free Cash Flow Per Share	12.70	5.86	3.98	2.08
Dividend Per Share	-	0.280	0.290	0.290
Dividend Growth	-	-3.45%	-	-
Gross Margin	32.46%	29.55%	28.34%	31.34%
Operating Margin	22.56%	19.61%	18.71%	23.62%
Profit Margin	17.87%	15.45%	14.71%	18.46%
Free Cash Flow Margin	18.41%	10.39%	10.56%	7.22%
EBITDA	5,915	4,142	2,645	2,502
EBITDA Margin	23.82%	20.40%	19.48%	24.17%
D&A For EBITDA	314.89	160.5	105.31	57.24
EBIT	5,601	3,981	2,539	2,444
EBIT Margin	22.56%	19.61%	18.71%	23.62%
Effective Tax Rate	23.34%	23.29%	24.26%	25.28%

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.